The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis
Abstract Background Indoleamine 2,3-dioxygenase (IDO) is a rate-limiting enzyme in the metabolism of tryptophan into kynurenine. It is considered to be an immunosuppressive molecule that plays an important role in the development of tumors. However, the association between IDO and solid tumor progno...
Main Authors: | Sen Wang, Jia Wu, Han Shen, Junjun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-06956-5 |
Similar Items
-
Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis
by: Haiyan Zhang, et al.
Published: (2022-09-01) -
The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis
by: Cheng-Peng Yu, et al.
Published: (2018-08-01) -
Prognostic value of ZEB-1 in solid tumors: a meta-analysis
by: Borong Chen, et al.
Published: (2019-06-01) -
Impact of IDO1 and IDO2 on the B Cell Immune Response
by: Lauren M. F. Merlo, et al.
Published: (2022-04-01) -
Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies
by: Bingxian Bian, et al.
Published: (2019-10-01)